StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Guided Therapeutics's total assets was $1.20M at Jun 30, 2026. For fiscal 2025 it was $1.32M, down 3.9% from the year before. Over ten years it grew -6.2% a year on average. The highest annual figure on record is $4.31M in fiscal 2011.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.32M-3.9%
FY2024Dec 31, 2024$1.38M-17.4%
FY2023Dec 31, 2023$1.67M-50.4%
FY2022Dec 31, 2022$3.37M+65.0%
FY2021Dec 31, 2021$2.04M+51.1%
FY2020Dec 31, 2020$1.35M+14.4%
FY2019Dec 31, 2019$1.18M+400.0%
FY2018Dec 31, 2018$236.00K-41.9%
FY2017Dec 31, 2017$406.00K-72.8%
FY2016Dec 31, 2016$1.49M-40.7%
FY2015Dec 31, 2015$2.52M-17.0%
FY2014Dec 31, 2014$3.03M-8.6%
FY2013Dec 31, 2013$3.32M-4.7%
FY2012Dec 31, 2012$3.48M-19.3%
FY2011Dec 31, 2011$4.31M+10.0%
FY2010Dec 31, 2010$3.92M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.20M+27.1%
Q1 FY2026Mar 31, 2026$1.60M+65.9%
Q4 FY2025Dec 31, 2025$1.32M-3.9%
Q3 FY2025Sep 30, 2025$903.00K-27.7%
Q2 FY2025Jun 30, 2025$940.00K-24.9%
Q1 FY2025Mar 31, 2025$967.00K-35.3%
Q4 FY2024Dec 31, 2024$1.38M-17.4%
Q3 FY2024Sep 30, 2024$1.25M-33.5%
Q2 FY2024Jun 30, 2024$1.25M-46.7%
Q1 FY2024Mar 31, 2024$1.49M-48.3%
Q4 FY2023Dec 31, 2023$1.67M-50.4%
Q3 FY2023Sep 30, 2023$1.88M-51.5%
Q2 FY2023Jun 30, 2023$2.35M+56.2%
Q1 FY2023Mar 31, 2023$2.89M+32.2%
Q4 FY2022Dec 31, 2022$3.37M+65.0%
Q3 FY2022Sep 30, 2022$3.87M+122.0%
Q2 FY2022Jun 30, 2022$1.50M-27.3%
Q1 FY2022Mar 31, 2022$2.19M-7.4%
Q4 FY2021Dec 31, 2021$2.04M+51.1%
Q3 FY2021Sep 30, 2021$1.74M+34.2%
Q2 FY2021Jun 30, 2021$2.07M+119.4%
Q1 FY2021Mar 31, 2021$2.36M+548.9%
Q4 FY2020Dec 31, 2020$1.35M+14.4%
Q3 FY2020Sep 30, 2020$1.30M+283.5%
Q2 FY2020Jun 30, 2020$942.00K+262.3%
Q1 FY2020Mar 31, 2020$364.00K-9.9%
Q4 FY2019Dec 31, 2019$1.18M+400.0%
Q3 FY2019Sep 30, 2019$339.00K-31.0%
Q2 FY2019Jun 30, 2019$260.00K-37.8%
Q1 FY2019Mar 31, 2019$404.00K-23.3%
Q4 FY2018Dec 31, 2018$236.00K-41.9%
Q3 FY2018Sep 30, 2018$491.00K-45.7%
Q2 FY2018Jun 30, 2018$418.00K-72.3%
Q1 FY2018Mar 31, 2018$527.00K-64.7%
Q4 FY2017Dec 31, 2017$406.00K-72.8%
Q3 FY2017Sep 30, 2017$905.00K-56.1%
Q2 FY2017Jun 30, 2017$1.51M–
Q1 FY2017Mar 31, 2017$1.49M–
Q4 FY2016Dec 31, 2016$1.49M–
Q3 FY2016Sep 30, 2016$2.06M–

More Guided Therapeutics figures

See a number that looks wrong?